Zepp Health Corp. · NYSE:ZEPP
Zepp Health — Q1 2026 Earnings Presentation
11 slides from Zepp Health's earnings presentation, Jun 8, 2026
Slide 1: Zepp Health Earnings Presentation First Quarter 2026
Zepp Health Earnings Presentation First Quarter 2026 Investor Relations 8 June 2026
Slide 2: Table of Contents
Table of Contents 01 1Q26 Financial and Operating Results 05 Adjusted Operating Expenses 02 Revenue 06 Net Income/ Earnings Performance 03 1Q26 Gross Margin 07 Liquidity Position 04 1Q26 Revenue and Gross Margin Trend 08 Business Outlook 2 Empowering Health, Inspiring Joy
Slide 3: 1Q26 Financial and Operating Results
1Q26 Financial and Operating Results Revenue • Meeting guidance range Adjusted Net • Attributable to Zepp ** Income $51.5 -$17.9 Million Million Amazfit-branded Units Shipped 0.6 Million 1Q25 0.5 Million Currency: USD **Adjusted net income, a non-GAAP financial measure, represents net income (i) sha
Slide 4: Revenue
Revenue US$ million +33.8% 52 61.4% 39 52 (67.3%) 39 60.6% (32.7%) 1Q25 1Q26 Xiaomi wearable products Amazfit-branded wearable products 4 Empowering Health, Inspiring Joy
Slide 5: 1Q26 Gross Margin
1Q26 Gross Margin Gross Profit (USD in Millions） Gross margin As % of sales 37.3% 37.7% 37.3% 37.7% 19.4 14.4 (67.3%) 19.4 14.4 (32.7%) 1Q25 1Q26 1Q25 1Q26 1Q25 1Q26 Xiaomi wearable products Amazfit-branded wearable products Amazfit-branded Total 5 Empowering Health, Inspiring Joy
Slide 6: 1Q26 Revenue and Gross Margin Trend
1Q26 Revenue and Gross margin trend Revenue (USD in Millions) Gross Margin (USD in Millions) & Gross Margin % 100 千 $85 40 40.4% 40.6% $76 40.3% $34 Between 40.0% 36.8% 36.8% 38.2% US$63-$68 36.2% $60 37.3% $29 37.7% $59 30 2% $52 30.0% 50 $22 $43 $22 $40 $41 100% $19 4% $39 20 9% $17 12% 100% $16 2
Slide 7: Adjusted Operating Expenses
Adjusted Operating Expenses Adjusted operating expenses Adjusted operating expenses as a % of total revenue (USD in Millions） 45 100% 90% 80% 70% 30 12 29.9% 60% 12 23.1% 50% 40% 15 16 35.8% 14 30% 31.8% 20% 10% 6 7 16.1% 14.4% 0 0% 1Q25 1Q26 1Q25 1Q26 G&A S&M R&D G&A S&M R&D 7 Empowering Health, In
Slide 8: Net Income/ Earnings Performance
Net Income/ Earnings Performance Net Income (loss) Attributable to Zepp Adjusted Net Income (loss) Attributable to Zepp (USD in Millions） (USD in Millions） 0.0 0.0 -10.0 -10.0 -20.0 -20.0 -18.1 -17.9 -19.7 -19.6 -30.0 -30.0 1Q25 1Q26 1Q25 1Q26 1Q25 1Q26 1Q25 1Q26 Earnings per ADS (Basic) Adjusted Ea
Slide 9: Liquidity Position
Liquidity Position Liquidity Position Cash and Cash Equivalents (USD in Millions） 400.0 Share Repurchase Program • Until 2026/03/31 - US$17.0 million 200.0 145.8 146.7 140.5 134.5 132.3 128.7 127.7 110.7 112.9 103.8 102.6 103.2 95.3 - 31 30 30 31 31 30 30 31 31 30 30 31 31 3. 6. 9. 2. 3. 6. 9. 2. 3.
Slide 10: Business Outlook
Business Outlook 1 2 3 4 5 • International • Expanding Product • New Product • Growing Value- • Strict Cost Control Expansion Categories Releases Added Service Revenue For the second quarter of 2026, the Company currently expects: • Net revenue to be between USD 63 million and USD 68 million, repres
Slide 11: Thank You!
Thank You! © 2022 Zepp Health Corporation. All Rights Reserved.